Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-2)
Efficacy and Safety of Ischemic Post-conditioning in Patients with Acute Ischemic Stroke After Mechanical Thrombectomy
1 other identifier
interventional
160
1 country
1
Brief Summary
Ischemic post-conditioning is a neuroprotective strategy that has been proven to attenuate reperfusion injury in animal models of stroke. The investigators have conducted a 3 + 3 dose-escalation trial to demonstrate the safety and tolerability of ischemic post-conditioning incrementally for a longer duration of up to 5 min × 4 cycles in stroke patients undergoing mechanical thrombectomy. The purpose of this study is to further determine the efficacy and safety of ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2023
CompletedFirst Posted
Study publicly available on registry
March 29, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedMarch 26, 2025
March 1, 2025
2 years
March 16, 2023
March 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Infarct volume at 24 hours
Infarct volume on MRI-DWI at 24 hours after randomization
24 hours after randomization
Secondary Outcomes (12)
Progression of infarct volume between baseline and 24 hours
Baseline and 24 hours after randomization
Progression of perfusion defect from baseline to 24 hours
Baseline and 24 hours after randomization
Progression of infarct volume between 2 hours and 24 hours
2 hours after randomization and 24 hours after randomization
Infarct volume at 5 days/at discharge
5 days after randomization or at discharge
The proportion of functional independence at 90 days
90 days after randomization
- +7 more secondary outcomes
Other Outcomes (5)
Safety outcome (mortality at 90 days)
90 days after randomization
Safety outcome (the proportion of symptomatic intracranial hemorrhage within 24 hours)
Within 24 hours after randomization
Safety outcome (the proportion of intracranial hemorrhage within 24 hours)
Within 24 hours after randomization
- +2 more other outcomes
Study Arms (2)
Ischemic post-conditioning group
EXPERIMENTALMechanical thrombectomy combined with ischemic post-conditioning
Control group
SHAM COMPARATORMechanical thrombectomy alone
Interventions
Ischemic post-conditioning will be applied after successful recanalization of the culprit artery achieve by thrombectomy. Ischemic post-conditioning consists of briefly repeated 4 cycles × 2 minutes of occlusion and reperfusion (equal duration) of the initially occluded artery using a balloon.
Successful recanalization was achieved by mechanical thrombectomy without subsequent ischemic post-conditioning.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years;
- Acute ischemic stroke within 24 hours from stroke onset (or from time last known well) to groin puncture;
- Previous mRS ≤ 2;
- Baseline NIHSS ≥ 6;
- Baseline ASPECTS ≥ 6;
- Unilateral middle cerebral artery occlusion with or without ipsilateral internal carotid artery occlusion;
- Successful recanalization after mechanical thrombectomy (eTICI 2b-3);
- Written informed consent provided by the patients or their legal relatives.
You may not qualify if:
- Confirmed or clinically suspected cerebral vasculitis/fibromuscular dysplasia;
- Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
- Complications related to thrombectomy, such as contrast agent extravasation, vascular perforation/rupture, dissection, and escape of thrombus;
- Stenting in the middle cerebral artery M1 segment/distal intracranial carotid artery during thrombectomy;
- \> 2 times of balloon dilations as rescue therapy due to angioplasty during thrombectomy;
- Patients with contraindications to MRI;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, 300350, China
Related Publications (2)
Wu L, Wei M, Zhang B, Zhang B, Chen J, Wang S, Luo L, Liu S, Li S, Ren C, Hess DC, Song H, Zhao W, Ji X. Safety and Tolerability of Direct Ischemic Postconditioning Following Thrombectomy for Acute Ischemic Stroke. Stroke. 2023 Sep;54(9):2442-2445. doi: 10.1161/STROKEAHA.123.044060. Epub 2023 Jul 27.
PMID: 37497674BACKGROUNDWu L, Zhang B, Zhao W, Ji X, Wei M. Ischemic post-conditioning in acute ischemic stroke thrombectomy: A phase-I duration escalation study. Front Neurosci. 2022 Dec 8;16:1054823. doi: 10.3389/fnins.2022.1054823. eCollection 2022.
PMID: 36523440BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 16, 2023
First Posted
March 29, 2023
Study Start
November 1, 2023
Primary Completion
November 1, 2025
Study Completion
February 1, 2026
Last Updated
March 26, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share